| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scavenger receptor binding | 1.76e-05 | 5 | 27 | 2 | GO:0005124 | |
| GeneOntologyMolecularFunction | N-formyl peptide receptor activity | 1.76e-05 | 5 | 27 | 2 | GO:0004982 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.59e-04 | 14 | 27 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | RAGE receptor binding | 1.83e-04 | 15 | 27 | 2 | GO:0050786 | |
| GeneOntologyMolecularFunction | amide binding | 6.59e-04 | 299 | 27 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.61e-03 | 44 | 27 | 2 | GO:0046915 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.50e-03 | 55 | 27 | 2 | GO:0017046 | |
| MousePheno | increased hemoglobin content | 1.43e-05 | 113 | 19 | 4 | MP:0005564 | |
| MousePheno | abnormal vomeronasal sensory neuron physiology | 1.75e-05 | 5 | 19 | 2 | MP:0011678 | |
| MousePheno | abnormal vomeronasal organ physiology | 1.75e-05 | 5 | 19 | 2 | MP:0013596 | |
| MousePheno | increased hematocrit | 2.00e-05 | 123 | 19 | 4 | MP:0002608 | |
| MousePheno | increased core body temperature | 1.35e-04 | 13 | 19 | 2 | MP:0011016 | |
| Domain | Formyl_pep_2/3_rcpt | 1.86e-06 | 2 | 26 | 2 | IPR027347 | |
| Domain | Formyl_rcpt-rel | 8.33e-05 | 10 | 26 | 2 | IPR000826 | |
| Domain | BTB | 1.39e-03 | 160 | 26 | 3 | PS50097 | |
| Domain | BTB | 1.94e-03 | 180 | 26 | 3 | SM00225 | |
| Domain | BTB/POZ_dom | 2.10e-03 | 185 | 26 | 3 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 2.23e-03 | 189 | 26 | 3 | IPR011333 | |
| Domain | BTB_2 | 2.46e-03 | 53 | 26 | 2 | PF02214 | |
| Domain | T1-type_BTB | 2.46e-03 | 53 | 26 | 2 | IPR003131 | |
| Domain | SPRY | 6.48e-03 | 87 | 26 | 2 | SM00449 | |
| Domain | SPRY | 7.53e-03 | 94 | 26 | 2 | PF00622 | |
| Domain | SPRY_dom | 7.53e-03 | 94 | 26 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 7.68e-03 | 95 | 26 | 2 | IPR001870 | |
| Domain | B302_SPRY | 7.68e-03 | 95 | 26 | 2 | PS50188 | |
| Domain | GPCR_Rhodpsn_7TM | 1.31e-02 | 670 | 26 | 4 | IPR017452 | |
| Domain | 7tm_1 | 1.36e-02 | 677 | 26 | 4 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.41e-02 | 685 | 26 | 4 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.45e-02 | 691 | 26 | 4 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.46e-02 | 692 | 26 | 4 | IPR000276 | |
| Domain | MFS_dom | 1.48e-02 | 134 | 26 | 2 | IPR020846 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 5.33e-05 | 8 | 20 | 2 | MM15110 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 5.33e-05 | 8 | 20 | 2 | M27370 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.26e-04 | 70 | 20 | 3 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.55e-04 | 75 | 20 | 3 | M39696 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.16e-04 | 84 | 20 | 3 | M27334 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 5.18e-04 | 24 | 20 | 2 | M18795 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.59e-03 | 42 | 20 | 2 | M174 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27317426 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23733341 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21543323 | ||
| Pubmed | Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes. | 5.80e-07 | 2 | 27 | 2 | 8198572 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17084101 | ||
| Pubmed | Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems. | 5.80e-07 | 2 | 27 | 2 | 26957543 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 9151906 | ||
| Pubmed | Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). | 5.80e-07 | 2 | 27 | 2 | 12172542 | |
| Pubmed | Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3. | 5.80e-07 | 2 | 27 | 2 | 32617132 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21501589 | ||
| Pubmed | Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis. | 5.80e-07 | 2 | 27 | 2 | 25512512 | |
| Pubmed | N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. | 5.80e-07 | 2 | 27 | 2 | 15465011 | |
| Pubmed | A novel rat lipoxin A4 receptor that is conserved in structure and function. | 5.80e-07 | 2 | 27 | 2 | 12746227 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 29544524 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 15879124 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19234121 | ||
| Pubmed | Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties. | 1.74e-06 | 3 | 27 | 2 | 22859307 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 12218158 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 12410796 | ||
| Pubmed | Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver. | 1.74e-06 | 3 | 27 | 2 | 36750693 | |
| Pubmed | Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. | 1.74e-06 | 3 | 27 | 2 | 12459252 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19342677 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 36834844 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 27207555 | ||
| Pubmed | Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ. | 1.74e-06 | 3 | 27 | 2 | 19497865 | |
| Pubmed | Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair. | 1.74e-06 | 3 | 27 | 2 | 31585047 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 37422776 | ||
| Pubmed | Functional expression of formyl peptide receptor family in human NK cells. | 1.74e-06 | 3 | 27 | 2 | 19843937 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 24067461 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31116781 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 17218541 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 20435922 | ||
| Pubmed | Fasting up-regulates ferroportin 1 expression via a Ghrelin/GHSR/MAPK signaling pathway. | 1.74e-06 | 3 | 27 | 2 | 28338217 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19498085 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 1612600 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 12470609 | ||
| Pubmed | Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. | 3.48e-06 | 4 | 27 | 2 | 12560218 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 15187149 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 31746387 | ||
| Pubmed | Convergence of FPR-rs3-expressing neurons in the mouse accessory olfactory bulb. | 5.80e-06 | 5 | 27 | 2 | 23664818 | |
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 31653840 | ||
| Pubmed | Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors. | 1.22e-05 | 7 | 27 | 2 | 19387439 | |
| Pubmed | Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. | 2.08e-05 | 9 | 27 | 2 | 9722950 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 36383665 | ||
| Pubmed | 3.81e-05 | 12 | 27 | 2 | 32294408 | ||
| Pubmed | 1.33e-04 | 22 | 27 | 2 | 35952650 | ||
| Pubmed | Cullin-3-KCTD10-mediated CEP97 degradation promotes primary cilium formation. | 2.01e-04 | 27 | 27 | 2 | 30404837 | |
| Cytoband | 19q13.3-q13.4 | 2.59e-05 | 13 | 27 | 2 | 19q13.3-q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 5.87e-04 | 1192 | 27 | 5 | chr19q13 | |
| GeneFamily | Formyl peptide receptors | 3.14e-06 | 3 | 19 | 2 | 198 | |
| GeneFamily | Solute carriers | 7.73e-03 | 395 | 19 | 3 | 752 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-08 | 186 | 27 | 5 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-06 | 139 | 27 | 4 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 160 | 27 | 4 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-06 | 168 | 27 | 4 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.01e-06 | 190 | 27 | 4 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.33e-06 | 193 | 27 | 4 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 194 | 27 | 4 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-06 | 195 | 27 | 4 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-06 | 195 | 27 | 4 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 75 | 27 | 3 | 3167beedef7304697e9577270cdeacfc9743cee1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 75 | 27 | 3 | 70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 75 | 27 | 3 | 26d6e54ed0a6c3ff57f6269c460177bc7b8bf979 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 5.69e-05 | 124 | 27 | 3 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.17e-05 | 134 | 27 | 3 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 7.99e-05 | 139 | 27 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-05 | 142 | 27 | 3 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-05 | 142 | 27 | 3 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 147 | 27 | 3 | c031fad0a4e192019775809968e46da54a111d27 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 147 | 27 | 3 | 684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-04 | 150 | 27 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 151 | 27 | 3 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 156 | 27 | 3 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.15e-04 | 157 | 27 | 3 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 158 | 27 | 3 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 159 | 27 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 161 | 27 | 3 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 161 | 27 | 3 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 163 | 27 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | COVID-19_Severe-multiplets|World / disease group, cell group and cell class | 1.28e-04 | 163 | 27 | 3 | 6db4271c2d47a9c333964f36d2c32207115e52cd | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 164 | 27 | 3 | 3281f2452cc6b11f3e030a3942002b9457dde6fe | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 164 | 27 | 3 | 939d4e3911fce185b986639c815de0a0389f6cfd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 165 | 27 | 3 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 166 | 27 | 3 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | droplet-Liver-LIVER|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | 90125bfdc34b0f9a471cefe6e8a637d5e5e00790 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 167 | 27 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | a038c522e4783cb62802f613d00bd5f3e3797199 | |
| ToppCell | droplet-Liver-LIVER-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | 4bbc59cc50a68b957125fb11a3b308fe1d542ce9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-04 | 168 | 27 | 3 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 169 | 27 | 3 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-04 | 169 | 27 | 3 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 170 | 27 | 3 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 170 | 27 | 3 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 171 | 27 | 3 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 171 | 27 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 172 | 27 | 3 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.50e-04 | 172 | 27 | 3 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 172 | 27 | 3 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | droplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 172 | 27 | 3 | d32731a56e113ff0ef7167b23959d69baf2068f9 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 2eb6e9fc3a3654f6f86fbd112e80a18814afd103 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 1.55e-04 | 174 | 27 | 3 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 174 | 27 | 3 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-04 | 176 | 27 | 3 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 177 | 27 | 3 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 177 | 27 | 3 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.72e-04 | 180 | 27 | 3 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 181 | 27 | 3 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.77e-04 | 182 | 27 | 3 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-04 | 182 | 27 | 3 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 183 | 27 | 3 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.80e-04 | 183 | 27 | 3 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 1.80e-04 | 183 | 27 | 3 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.80e-04 | 183 | 27 | 3 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.83e-04 | 184 | 27 | 3 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-04 | 187 | 27 | 3 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 188 | 27 | 3 | 649d27b2ef735b481ec0ed4f7a9b39aacc472a78 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.95e-04 | 188 | 27 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 1.95e-04 | 188 | 27 | 3 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 189 | 27 | 3 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-04 | 189 | 27 | 3 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-04 | 190 | 27 | 3 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 190 | 27 | 3 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 190 | 27 | 3 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-04 | 191 | 27 | 3 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 191 | 27 | 3 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 2.04e-04 | 191 | 27 | 3 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 2.04e-04 | 191 | 27 | 3 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 2.11e-04 | 193 | 27 | 3 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.11e-04 | 193 | 27 | 3 | 42775588e788c330aade07e54b208f1c2eea3ab3 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 2.11e-04 | 193 | 27 | 3 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Control-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 2.14e-04 | 194 | 27 | 3 | 7ab808dd1876b0eec2831caa16d04fd859b1dc50 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 194 | 27 | 3 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-04 | 194 | 27 | 3 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 2.14e-04 | 194 | 27 | 3 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 195 | 27 | 3 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| Drug | NSC342435 | 1.01e-07 | 37 | 27 | 4 | CID000334935 | |
| Drug | t-boc-MLP | 8.11e-06 | 4 | 27 | 2 | CID000125627 | |
| Drug | cyclooctylamine | 1.35e-05 | 5 | 27 | 2 | CID000002903 | |
| Drug | bacteriochlorin A | 2.03e-05 | 6 | 27 | 2 | CID000159279 | |
| Drug | L-phosphatidyl-glycerol | 2.03e-05 | 6 | 27 | 2 | CID000454706 | |
| Drug | dimethylfumarate | 2.03e-05 | 6 | 27 | 2 | CID000010262 | |
| Drug | deazaAdo | 2.48e-05 | 48 | 27 | 3 | CID000001651 | |
| Drug | L-valine methyl ester hydrochloride | 3.78e-05 | 8 | 27 | 2 | CID000094285 | |
| Drug | Fmlp Ome | 3.78e-05 | 8 | 27 | 2 | CID000122066 | |
| Drug | AC1L9IXO | 3.78e-05 | 8 | 27 | 2 | CID000445997 | |
| Drug | AC1L524D | 3.78e-05 | 8 | 27 | 2 | CID000196667 | |
| Drug | AC1L252K | 4.85e-05 | 9 | 27 | 2 | CID000015061 | |
| Drug | antiflammin-2 | 7.40e-05 | 11 | 27 | 2 | CID000003612 | |
| Drug | 1,3-dipropyl-7-methylxanthine | 8.87e-05 | 12 | 27 | 2 | CID000161713 | |
| Drug | Cyclosporin G | 1.05e-04 | 13 | 27 | 2 | CID006436101 | |
| Drug | Fnllp | 1.22e-04 | 14 | 27 | 2 | CID000119508 | |
| Drug | AC1Q6JQD | 1.22e-04 | 14 | 27 | 2 | CID000124337 | |
| Drug | BW A1433U | 1.41e-04 | 15 | 27 | 2 | CID000122071 | |
| Drug | dA-dT | 1.41e-04 | 15 | 27 | 2 | CID000020570 | |
| Drug | Fp-O | 1.48e-04 | 87 | 27 | 3 | CID000024267 | |
| Drug | heme b | 1.56e-04 | 444 | 27 | 5 | CID000004973 | |
| Drug | AC1Q6QQN | 1.61e-04 | 16 | 27 | 2 | CID000004365 | |
| Drug | fMLPL | 1.61e-04 | 16 | 27 | 2 | CID000121909 | |
| Drug | Ethionamide | 1.82e-04 | 17 | 27 | 2 | ctd:D005000 | |
| Drug | quin2 | 1.91e-04 | 95 | 27 | 3 | CID000104841 | |
| Drug | HQL-79 | 2.05e-04 | 18 | 27 | 2 | CID006540277 | |
| Drug | flosulide | 2.80e-04 | 21 | 27 | 2 | CID000071246 | |
| Drug | 2,5-dimethoxy-4-iodoamphetamine | 3.54e-04 | 117 | 27 | 3 | CID000001229 | |
| Drug | AC1L9FWV | 4.00e-04 | 25 | 27 | 2 | CID000444206 | |
| Drug | F-Peptide | 4.32e-04 | 26 | 27 | 2 | CID000123875 | |
| Drug | 2-aminoethyl diphenylborinate | 4.50e-04 | 127 | 27 | 3 | CID000001598 | |
| Drug | Sulfobromophthalein | 4.67e-04 | 27 | 27 | 2 | ctd:D013448 | |
| Drug | Bplplp | 4.67e-04 | 27 | 27 | 2 | CID000125628 | |
| Drug | glaxo | 5.02e-04 | 28 | 27 | 2 | CID000047897 | |
| Drug | Csh Cyclosporin | 5.02e-04 | 28 | 27 | 2 | CID006436249 | |
| Drug | 5-deazariboflavin | 5.02e-04 | 28 | 27 | 2 | CID000159867 | |
| Drug | Tyr-Ala | 6.57e-04 | 32 | 27 | 2 | CID004078684 | |
| Drug | GI-3 | 6.88e-04 | 147 | 27 | 3 | CID011957433 | |
| Drug | Azathioprine | 8.29e-04 | 639 | 27 | 5 | ctd:D001379 | |
| Drug | BAY u3405 | 8.32e-04 | 36 | 27 | 2 | CID000005036 | |
| Drug | W peptide | 9.27e-04 | 38 | 27 | 2 | CID000456181 | |
| Drug | sphingosine kinase inhibitor | 1.03e-03 | 40 | 27 | 2 | CID000753704 | |
| Drug | 2bub | 1.03e-03 | 40 | 27 | 2 | CID005494422 | |
| Drug | gabapentin | 1.03e-03 | 169 | 27 | 3 | CID000003446 | |
| Drug | Eli | 1.08e-03 | 41 | 27 | 2 | CID009549220 | |
| Drug | 18-hydroxycorticosterone | 1.13e-03 | 42 | 27 | 2 | CID000011222 | |
| Disease | Papillary Renal Cell Carcinoma | 1.51e-04 | 128 | 24 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.51e-04 | 128 | 24 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.51e-04 | 128 | 24 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.51e-04 | 128 | 24 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.51e-04 | 128 | 24 | 3 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.32e-04 | 148 | 24 | 3 | C0279702 | |
| Disease | Barrett's esophagus | 2.37e-04 | 28 | 24 | 2 | EFO_0000280 | |
| Disease | Tourette syndrome | 7.58e-04 | 50 | 24 | 2 | EFO_0004895 | |
| Disease | alcohol consumption measurement | 2.85e-03 | 1242 | 24 | 5 | EFO_0007878 | |
| Disease | bone fracture | 3.73e-03 | 112 | 24 | 2 | EFO_0003931 | |
| Disease | lipoprotein A measurement | 3.73e-03 | 112 | 24 | 2 | EFO_0006925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIRTCTINGTWSGVM | 3211 | Q7Z407 | |
| ASTARVVVWREMGVS | 966 | Q96MI9 | |
| IWDTGGQERFRSMVS | 61 | Q96AH8 | |
| GRTTTAMVVAVLAFW | 666 | Q9ULE6 | |
| LVIWVAGFRMTRTVT | 46 | P25090 | |
| SWMGVTVSVDGRVLR | 1936 | Q8NDA2 | |
| LVIWVAGFRMTRTVN | 46 | P25089 | |
| IEMSTTGWVGRFRPS | 346 | P27487 | |
| SWVGRMLRSQTGSVE | 171 | Q8IXW0 | |
| MSRGRCTGLIVASWV | 136 | Q8NGE8 | |
| RSGLLTVMVWVSSIF | 206 | Q92847 | |
| WMTTVSIGVLVARFF | 381 | Q6ZNA5 | |
| FISTRHGTWVMSRIS | 211 | Q99518 | |
| WSEVTRMTSGRSGVG | 591 | Q14145 | |
| QTWGEFRVVERTITM | 306 | O15382 | |
| WTTTSRRAVTMTVVG | 221 | Q9NSA0 | |
| FEAVTTGEMRVGWAR | 1091 | P21817 | |
| TWTVTRFRGMISTQP | 446 | Q9Y597 | |
| VSGITRRVFMWTVSG | 6 | Q8N5N7 | |
| TVVTSGVMQIGWATR | 366 | Q96DX4 | |
| RRMSVVYGIGTWSVL | 11 | A0A096LP01 | |
| WSVTRFRGMISTQPG | 456 | Q8TBC3 | |
| ITGIMGTVAFTWLRR | 351 | Q9NP59 | |
| TRTMTFGWHRSETLG | 131 | Q99726 | |
| VGTMWRFRVQVSESG | 426 | Q96T88 | |
| VVSFSTLIMWRRGHG | 321 | Q8N831 | |
| FVASVGVRWMIGVTE | 346 | Q9NRZ5 |